More on INDV

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+45.1% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Indivior (NQ:INDV)
Delayed: 39.80 -0.45 (1.12%)
Prev. Close $40.25  
Open$40.14 
52 Wk High$ 
52 Wk Low$ 
Day High$40.81 
Day Low$39.56 
P/E N/A  
EPS$ 
Volume1,488,844 

Friends, Peers and Foes (?): ASIX, BAH, BWA, CEVA, CRH (more...)

Jun 23, 2026 05:24 PM Form 4 Indivior Pharmaceuticals For: Jun 22 Filed by: Ciaffoni Joseph
Jun 18, 2026 04:25 AM Barclays Starts Indivior (INDV) at Overweight
Jun 12, 2026 04:11 PM Form 4 Indivior Pharmaceuticals For: Jun 11 Filed by: Heidbreder Christian
Jun 11, 2026 11:20 AM Form 144 Indivior Pharmaceuticals Filed by: Heidbreder Christian
Jun 10, 2026 06:04 AM Form 4 Indivior Pharmaceuticals For: Jun 08 Filed by: Preblick Ryan
Jun 8, 2026 03:24 PM Form 144/A Indivior Pharmaceuticals Filed by: Preblick Ryan
Jun 8, 2026 01:58 PM Form 144 Indivior Pharmaceuticals Filed by: Preblick Ryan
May 20, 2026 09:00 AM New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization
May 15, 2026 04:04 PM Form 8-K Indivior Pharmaceuticals For: May 13
May 15, 2026 09:19 AM Form SCHEDULE 13G/A Indivior Pharmaceuticals Filed by: Madison Avenue Partners, LP
View All Articles

Entities mentioned with INDV

View All Entities